| 2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee|
|FDA Comment Number :||EC18|
|Submitter :||Dr. David Healy||Date & Time:||09/02/2004 05:09:23|
|Organization :||Cardiff University|
| In recent weeks, Pfizer have posted on the FDA website in connection with a forthcoming PDAC hearing an ad hominem attack on me. This was apparently cleared before posting by FDA's chief counsel,Daniel Troy, who has had a prior close working relationship with Pfizer. The attached material constitutes a preliminary response.